VECSYN

Synthetic species of the mosquito vectors of human disease: from hybrid genetics to a new type of vector control

 Coordinatore IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore United Kingdom [UK]
 Totale costo 1˙497˙606 €
 EC contributo 1˙497˙606 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2013-StG
 Funding Scheme ERC-SG
 Anno di inizio 2014
 Periodo (anno-mese-giorno) 2014-02-01   -   2019-01-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

 Organization address address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
city: LONDON
postcode: SW7 2AZ

contact info
Titolo: Dr.
Nome: Nikolai
Cognome: Windbichler
Email: send email
Telefono: +44 207 594 5395
Fax: +44 207 594 5439

UK (LONDON) hostInstitution 1˙497˙606.00
2    IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

 Organization address address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
city: LONDON
postcode: SW7 2AZ

contact info
Titolo: Ms.
Nome: Brooke
Cognome: Alasya
Email: send email
Telefono: +44 207 594 1181
Fax: +44 207 594 1418

UK (LONDON) hostInstitution 1˙497˙606.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

genome    experimental    genes    genetic    malaria    generation    disease    species    strains    mosquitoes    construction    reproductive    vector    barriers    viral    artificial    synthetic    arising    mosquito   

 Obiettivo del progetto (Objective)

'In this project I aim to generate the first synthetic species of mosquitoes derived from Anopheles gambiae, the main vector of malaria, and also from Aedes albopictus, a vector of several viral diseases, that has recently invaded Europe. The experimental generation of artificial species will prove invaluable to shed light on major biological questions concerning reproductive isolation. Furthermore, I propose a novel strategy to reduce the incidence of disease transmitted by these vectors based on the release of synthetic strains. Mathematical modelling indicates this to be a highly effective way to simultaneously suppress and replace a wild disease transmitting vector population with disease-refractory insects. In Objective 1, I will identify genes that constitute the natural reproductive barriers in mosquitoes by analyzing the genetic makeup of progeny arising from crosses of related mosquito species. Such genes can be drawn upon for the construction of artificial barriers and help to reveal the mechanisms underlying speciation in mosquitoes. In Objective 2, I will introduce, into the mosquito genome, artificial reproductive barriers that cause post-zygotic lethality in hybrids but that will not otherwise affect the mating propensity of parent and synthetic species. I propose a generalizable approach for the construction of artificial species barriers utilizing synthetic transcriptional activators. In Objective 3, synthetic strains will be transformed with genes that interfere with the replication of malaria or viral pathogens and their transmission to humans and tested in cage experiments to validate their efficacy for vector control. To carry out these experimental activities I will utilize cutting-edge next generation genetic mapping and site-specific genome-editing technologies. Knowledge arising from the development of synthetic mosquito strains will be applicable to beneficial species with a range of applications in biosafety, agriculture and biotechnology.'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

BIOTENSORS (2014)

Biomedical Data Fusion using Tensor based Blind Source Separation

Read More  

FUNMETA (2012)

Metabolomics of fungal diseases: a systems biology approach for biomarkers discovery and therapy

Read More  

STAC (2011)

Strategic Conversation

Read More